Search research articles
Contact Us
Filters
Showing results (121-130 of 128) with videos related to
Page
of 13
Sort By:
You have reached the last page of results.
This site can display upto 128 results.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 9, 2019
Outcome of Fludarabine-Based Conditioning in High-Risk Aplastic Anemia Patients Undergoing Matched Related Donor Transplantation: A Single-Center Study from Pakistan
Qamar Un Nisa Chaudhry, Raheel Iftikhar, Tariq Mehmood Satti, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 28, 2020
Single-Agent Cyclosporine for Graft-versus-Host Disease Prophylaxis in Patients with Acquired Aplastic Anemia Receiving Fludarabine-Based Conditioning
Raheel Iftikhar, Qamar Un Nisa Chaudhry, Syed Kamran Mahmood, et al.
Malaria Journal
|
November 11, 2025
Effectiveness of tafenoquine and primaquine for radical cure of Plasmodium vivax: a meeting report from dissemination of results of the EFFORT trial to stakeholders in Pakistan
Bushra Qurashi, Shan-E-Zehra Zaidi, Muhammad Mushtaque, et al.
Clinical Hematology International
|
October 1, 2021
Comparison of Conventional Cyclophosphamide <i>versus</i> Fludarabine-Based Conditioning in High-Risk Aplastic Anemia Patients Undergoing Matched-Related Donor Transplantation
Raheel Iftikhar, Qamar Un Nisa Chaudhry, Tariq Mehmood Satti, et al.
Blood Reviews
|
November 14, 2020
Allogeneic hematopoietic stem cell transplantation in aplastic anemia: current indications and transplant strategies
Raheel Iftikhar, Qamar Un Nisa Chaudhry, Faiz Anwer, et al.
The Journal of Allergy and Clinical Immunology
|
October 16, 2025
Caspase 1-deficient humans survive into late adulthood despite dramatically lower canonical inflammasome activity
John Dominy, Christopher Koch, Christelle Arnold, et al.
The Lancet. Infectious Diseases
|
February 14, 2026
Effectiveness and safety of 7-day high-dose primaquine and single-dose tafenoquine versus 14-day low-dose primaquine in patients with Plasmodium vivax malaria (EFFORT): a multicentre, open-label, randomised, controlled, superiority trial
Tamiru Shibiru Degaga, Ayodhia Pitaloka Pasaribu, Rupam Tripura, et al.
Nature
|
June 17, 2026
Analysis of 173,303 exomes and genomes in the Pakistan Genome Resource
Christopher Koch, Shareef Khalid, Maleeha Zaman Khan, et al.
Page
of 13
Search research articles
Search
Showing results (121-130 of 128) with videos related to
Sort By:
Page
of 13
You have reached the last page of results.
This site can display upto 128 results.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 9, 2019
Outcome of Fludarabine-Based Conditioning in High-Risk Aplastic Anemia Patients Undergoing Matched Related Donor Transplantation: A Single-Center Study from Pakistan
Qamar Un Nisa Chaudhry, Raheel Iftikhar, Tariq Mehmood Satti, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 28, 2020
Single-Agent Cyclosporine for Graft-versus-Host Disease Prophylaxis in Patients with Acquired Aplastic Anemia Receiving Fludarabine-Based Conditioning
Raheel Iftikhar, Qamar Un Nisa Chaudhry, Syed Kamran Mahmood, et al.
Malaria Journal
|
November 11, 2025
Effectiveness of tafenoquine and primaquine for radical cure of Plasmodium vivax: a meeting report from dissemination of results of the EFFORT trial to stakeholders in Pakistan
Bushra Qurashi, Shan-E-Zehra Zaidi, Muhammad Mushtaque, et al.
Clinical Hematology International
|
October 1, 2021
Comparison of Conventional Cyclophosphamide <i>versus</i> Fludarabine-Based Conditioning in High-Risk Aplastic Anemia Patients Undergoing Matched-Related Donor Transplantation
Raheel Iftikhar, Qamar Un Nisa Chaudhry, Tariq Mehmood Satti, et al.
Blood Reviews
|
November 14, 2020
Allogeneic hematopoietic stem cell transplantation in aplastic anemia: current indications and transplant strategies
Raheel Iftikhar, Qamar Un Nisa Chaudhry, Faiz Anwer, et al.
The Journal of Allergy and Clinical Immunology
|
October 16, 2025
Caspase 1-deficient humans survive into late adulthood despite dramatically lower canonical inflammasome activity
John Dominy, Christopher Koch, Christelle Arnold, et al.
The Lancet. Infectious Diseases
|
February 14, 2026
Effectiveness and safety of 7-day high-dose primaquine and single-dose tafenoquine versus 14-day low-dose primaquine in patients with Plasmodium vivax malaria (EFFORT): a multicentre, open-label, randomised, controlled, superiority trial
Tamiru Shibiru Degaga, Ayodhia Pitaloka Pasaribu, Rupam Tripura, et al.
Nature
|
June 17, 2026
Analysis of 173,303 exomes and genomes in the Pakistan Genome Resource
Christopher Koch, Shareef Khalid, Maleeha Zaman Khan, et al.
Page
of 13